Business description: C-Rad AB

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Number of employees: 98

Sales by Activity: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

Positioning

261M 301M 425M 469M 442M

Geographical breakdown of sales: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

EMEA (Excluding Sweden)

- - - - 168M

APAC

- - 119M 210M 167M

Americas

- - 85.97M 72.7M 98.75M

Sweden

21.73M 8.67M - - 8.57M

South and Latin America

655K 689K - - -

Dach (Germany, Austria, Switzerland)

40.6M 31.88M - - -

The Rest of The Nordic Countries

5.37M 12.11M - - -

EMEA

- - 220M 186M -

France

13.91M 15.27M - - -

ROE (Other Europe)

46.27M 77.98M - - -

Asia

82.07M 83.99M - - -

USA

50.55M 70.75M - - -

Executive Committee: C-Rad AB

Manager TitleAgeSince
Chief Executive Officer 56 01/02/2026
Chief Executive Officer - 20/10/2025
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 58 31/10/2019
Corporate Officer/Principal 58 20/10/2025

Composition of the Board of Directors: C-Rad AB

Director TitleAgeSince
Director/Board Member 52 31/12/2016
Director/Board Member 60 06/05/2021
Chairman 61 04/05/2023
Director/Board Member 60 04/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 55 22/07/2007

Shareholders: C-Rad AB

NameStocks%Valuation
Svea Bank AB
11.93 %
3,924,969 11.93 % 15 M kr
9.926 %
3,266,170 9.926 % 12 M kr
Cervantes Capital AB
9.072 %
2,984,997 9.072 % 11 M kr
4.352 %
1,432,078 4.352 % 5 M kr
3.647 %
1,200,000 3.647 % 5 M kr
NameStocks%Valuation
44.01 %
379,762 44.01 % 1 M kr
30.49 %
263,125 30.49 % 986 908 kr
Cervantes Capital AB
13.91 %
120,000 13.91 % 450 086 kr
Svea Bank AB
11.59 %
100,000 11.59 % 375 072 kr

Holdings: C-Rad AB

NameStocks%Valuation
188,5000.57% 707 011 $

Company details: C-Rad AB

C-RAD AB

Sjukhusvaegen 12K

753 09, Uppsala

+46 18 666 930

http://www.c-rad.se
address C-Rad AB(CRAD B)

Other Advanced Medical Equipment & Technology

Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-3.49%+4.82%+27.30% 126M
-1.27%-1.91%+21.18%+3.05% 212B
+0.08%-1.95%-1.16%-23.39% 139B
-2.21%+1.82%-23.79%+19.10% 133B
+0.90%+6.32%-54.14%-3.45% 70.19B
+2.45%+7.09%+11.89%+12.65% 51.14B
-0.28%+8.57%-15.66%-20.88% 50.09B
-0.18%-0.95%+21.21%+10.21% 39.48B
+0.59%+2.93%+38.36%+36.31% 36.79B
+0.69%+4.35%+104.56%+7.30% 29.92B
Average +0.46%+3.25%+10.73%+6.82% 76.15B
Weighted average by Cap. -0.51%+3.55%+3.39%+1.65%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.60SEK
Average target price
45.00SEK
Spread / Average Target
+26.40%

Quarterly revenue - Rate of surprise